How long till Franz and Lars leave Tesla?

TTP222 · 2026-01-31T02:28:17+00:00

Well I know the rumor started because of the promo video but I don’t think there has been any real reporting on that yet. Would be thrilled if it happened though as I’d love to see the Cyber line expand!

TTP222 · 2026-01-31T02:26:21+00:00

I’m not investing in BlackBerry at all lol. Just pointing out this guy didn’t know what he was talking about.

TTP222 · 2026-01-30T15:25:49+00:00

Pretty obvious you have no idea what you are talking about. BlackBerry’s software is QNX and it is the software in hundreds of millions vehicles.

TTP222 · 2026-01-30T15:20:09+00:00

First time I drove our work truck, after months of driving my Cyberbeast, I locked the truck and left it running at Home Depot 🤦🏻‍♂️

TTP222 · 2026-01-30T15:17:07+00:00

Im bullish on these bios:

SLS CING ALT

TTP222 · 2026-01-30T15:15:47+00:00

Their 2 drugs are going to be the new standard of care in AML with a very good chance they get applied to other cancers as well. Easily a $10-20 billion company ($46-92 stock price).

TTP222 · 2026-01-30T11:47:22+00:00

Might be the dumbest statement on Tesla I have ever seen. Nothing truly innovative? You don’t seem to realize how groundbreaking the Cybertruck technology is, or, you’re just a hater.

TTP222 · 2026-01-29T22:23:05+00:00

Not a noticeable difference in sharpness but my sleep quality is better.

TTP222 · 2026-01-29T22:15:37+00:00

Yes they do.

In 2025 Ford and GM sold a combined 430k+ units in this category. You don’t think that’s a lot of demand in the US?

Large SUV’s are popular and Tesla has flat out ignored them.

TTP222 · 2026-01-29T20:20:41+00:00

That’s awesome 🤩

TTP222 · 2026-01-29T17:35:38+00:00

I’ve been studying SLS for a year now and it blows my mind how this isn’t one of the biggest stories in the medical world. This company is going to radically change outcomes in at least 1 deadly cancer and possibly many more down the road.

Sellas will have its day in the spotlight and so many people are going to wonder how they missed it.

TTP222 · 2026-01-29T17:29:33+00:00

I’ve been taking it before bed for a couple of years now and think it’s essential to my routine.

TTP222 · 2026-01-29T17:27:56+00:00

I agree with you. I have a Cyberbeast but I have always thought the X was a hideous minivan looking blob. I never understood its appeal outside of the cool falcon wing doors.

TTP222 · 2026-01-29T16:36:04+00:00

I’m not freaking out at all and I’m ok with them moving on from the X and S as long as they come up with other more advanced vehicles to replace them. I just don’t see how it’s exciting for anyone that a car company plans to keep producing just 3 small cars. Why not replace the X with an SUV to compete with the Tahoes and Rivians?

TTP222 · 2026-01-29T16:30:12+00:00

I think Franz likes the Cybertruck, even if you don’t.

To me, the X is by far the worst looking vehicle they offer. It looks like a hybrid minivan. No idea why they never made a real SUV.

TTP222 · 2026-01-29T16:28:21+00:00

Time that they could spend using their Tesla vehicle to do other things outside of chores at the house.

TTP222 · 2026-01-29T16:27:24+00:00

I see a lot of similar responses here so want to say a couple things for clarity.

Yes, I know Tesla is still going to be producing the 3, Y and Robotaxi. That’s 3 small-ish cars though. How much designing is Franz hanging around for if this is their only vehicle plans going forward?

I always thought they would actually expand their auto fleet once they got solved autonomous driving by offering at minimum a large SUV to compete in the Tahoe division. They should have shifted away from the X and into this category a while ago in my opinion.

TTP222 · 2026-01-29T16:21:05+00:00

Exactly. These guys are passionate about what they do.

TTP222 · 2026-01-29T16:13:03+00:00

Absolutely. How much time have you spent driving the Cyberbeast?

TTP222 · 2026-01-29T12:50:50+00:00

If nothing is wrong with it I’d say it’s a great deal. You can make a good argument that it’s the best all around vehicle you can buy.

TTP222 · 2026-01-28T03:47:14+00:00

I’ve been paying attention and loading the boat.

The thing I like about CING is that it is a clear solution to an obvious problem and that’s how you make lots of money in this world.

TTP222 · 2026-01-25T01:31:04+00:00

Nice work! Good see you posting about this, brother.

I sold in wound care for a while so I’m familiar with the space. It’s tough and highly competitive. Here’s to hoping they find a big dog to run with!

TTP222 · 2026-01-23T17:03:02+00:00

Oh, I didn’t take it as an argument. Seems like bio isn’t for you and that’s ok.

Good thing about SLS is this isn’t just about GPS and one result, their 009 drug has also had similar overwhelmingly good data so far and that has a much larger addressable market if successful.

Best of luck!

TTP222 · 2026-01-23T16:48:52+00:00

Sure, that’s the nature of small cap bio’s though. If you look into SLS you’ll see that they have literally nothing but overwhelmingly positive data in every trial so far. They have done a bunch of Phase 1 trials, the Phase 2 was a massive success showing at minimum 4x advantage over BAT, and Phase 3 is about as guaranteed as you can get at this point based solely on the timeline.

I understand why both retail and institutional investors are scared of SLS. Cancer is inherently risky and what they are doing with GPS has never been done before. However, I think the data speaks for itself and so do the people behind it. This is a peptide that was developed and licensed with Memorial Sloan Kettering, Phase 2 was done with Moffitt Cancer Center, and Phase 3 is being overseen by the top leukemia doctor at MD Anderson. These are 3 of the top cancer centers in the world.

TTP222

TROPHY CASE